-
1
A Novel Case of Hyperglycemic Hyperosmolar State After the Use of Teprotumumab in a Patient With Thyroid Eye Disease
Published 2022-07-01Subjects: “…Teprotumumab…”
Get full text
Article -
2
Teprotumumab in thyroid eye disease: wonder drug or great divider?
Published 2023-06-01Subjects: Get full text
Article -
3
Severe Hyperglycemia with Teprotumumab for Treatment of Thyroid Eye Disease
Published 2024-03-01Subjects: Get full text
Article -
4
A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease
Published 2021-06-01Subjects: “…Teprotumumab…”
Get full text
Article -
5
Effects of teprotumumab on patients with long-standing, active thyroid eye disease
Published 2022-06-01Subjects: “…Teprotumumab…”
Get full text
Article -
6
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
Published 2021-04-01Subjects: Get full text
Article -
7
Long-Term Follow-Up of a Case of Severe Hyperglycemia Requiring Hospitalization after Third Dose of Teprotumumab: A Case Report
Published 2024-02-01Subjects: Get full text
Article -
8
Teprotumumab versus intravenous methylprednisolone in thyroid eye disease: A systematic review
Published 2024-10-01Subjects: Get full text
Article -
9
Orbital lymphocyte populations in three states of thyroid eye disease
Published 2023-09-01Subjects: Get full text
Article -
10
-
11
Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
Published 2022-11-01Subjects: Get full text
Article -
12
Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report
Published 2023-04-01Subjects: “…teprotumumab…”
Get full text
Article -
13
Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
Published 2022-06-01Subjects: Get full text
Article -
14
The association of race with thyroid eye disease presentation and outcomes
Published 2024-01-01Subjects: Get full text
Article -
15
Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review
Published 2019-12-01Subjects: Get full text
Article -
16
Immune checkpoints: new insights into the pathogenesis of thyroid eye disease
Published 2024-05-01Subjects: Get full text
Article -
17
Precision Medicine in Graves’ Disease and Ophthalmopathy
Published 2021-10-01Subjects: Get full text
Article -
18
A case of pretibial myxedema treated with teprotumumab
Published 2021-10-01Subjects: Get full text
Article -
19
A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsResearch in context
Published 2025-02-01Subjects: “…Teprotumumab…”
Get full text
Article -
20
Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series
Published 2022-05-01Subjects: “…Teprotumumab…”
Get full text
Article